0001179110-22-001943.txt : 20220302 0001179110-22-001943.hdr.sgml : 20220302 20220302175103 ACCESSION NUMBER: 0001179110-22-001943 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220228 FILED AS OF DATE: 20220302 DATE AS OF CHANGE: 20220302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOOVER R DAVID CENTRAL INDEX KEY: 0001186033 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 22705457 MAIL ADDRESS: STREET 1: C/O EDGEWELL PERSONAL CARE COMPANY STREET 2: 1350 TIMBERLAKE MANOR PARKWAY CITY: CHESTERFIELD STATE: MO ZIP: 63017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825497352 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 4 1 edgar.xml FORM 4 - X0306 4 2022-02-28 0 0001739104 Elanco Animal Health Inc ELAN 0001186033 HOOVER R DAVID C/O ELANCO ANIMAL HEALTH INCORPORATED 2500 INNOVATION WAY GREENFIELD IN 46140 1 0 0 0 See Remarks Common Stock 2022-03-01 4 P 0 5000 28.6645 A 110000 I Revocable Trust Common Stock 2022-03-02 4 P 0 5000 29.00 A 115000 I Revocable Trust Common Stock 39267 D Common Stock 15920 I Suzanne A. Hoover Revocable Trust Deferred Stock Units 2022-02-28 4 A 0 375.4548 28.41 A Common Stock 375.4548 20395.336 D Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 1, 2022 with purchase prices ranging from $28.43 to $28.899 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Reflects the weighted average price of 5,000 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on March 2, 2022 with purchase prices ranging from $28.88 to $29.12 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Mr. Hoover elected to defer his director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock. The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan. The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $28.41 on February 28, 2022. Chairman of the Elanco Board of Directors /s/ Collin G. Smyser, as Attorney-in-Fact for R. David Hoover 2022-03-02